Insulet Corp
(NAS:PODD)
$
161.27
+2.99 (+1.89%)
Market Cap: 11.17 Bil
Enterprise Value: 11.64 Bil
PE Ratio: 37.51
PB Ratio: 8.57
GF Score: 81/100 Insulet Corp at Bank of America Global Healthcare Conference Transcript
May 13, 2026 / 04:20PM GMT
Release Date Price:
$148.84
(-6.01%)
Travis Steed
Bank of America - Analyst
Good morning, everybody. Travis Steeve, the Bank of America MedTech analyst.
Next up, we are glad to have Inflip here. We have Flavio Pease, Chief Financial Officer. Welcome.
Flavia Pease
Insulet Corp - Chief Financial Officer, Executive Vice President
Thank you, Travis. Great to be here.
Thank you all for your interest in Insulant. Looking forward to the chat.
Questions & Answers
Travis Steed
Bank of America - Analyst
Thank you. Maybe we'll start with seasonality in Q1. Deductibles getting reset. It's not really a new dynamic and other companies haven't called it out. So why was it kind of stronger than what you've kind of seen historically in Q1?
Flavia Pease
Insulet Corp - Chief Financial Officer, Executive Vice President
Yeah, to your point, deductibles we set every year, and there's normal seasonality in the category. We saw that in 2023 and in 2024. Last year was a little masked. We didn't see
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot